Trial Profile
A prospective randomised double-blind parallel-group placebo-controlled active-reference study of gaboxadol in primary insomnia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Jul 2007
Price :
$35
*
At a glance
- Drugs Gaboxadol - Ovid Therapeuticsgaboxadol (Primary)
- Indications Insomnia
- Focus Registrational; Therapeutic Use
- 20 Nov 2005 New trial record.